WHO’s antibacterial pipeline reports
The antibacterial pipeline report details preclinical and clinical studies of traditional and novel antibacterial agents worldwide. It offers an assessment of criteria for innovation, such as the known absence of cross-resistance to drugs or new targets or modes of action. The vaccine pipeline report lists 61 vaccine candidates in various stages of clinical development and a further 94 candidates that are in the preclinical stage. It also discusses WHO’s position on the science of vaccines and their role in reducing the spread of AMR and saving lives, and the case for new investments.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
